Govt Job: For the post of Director Vigilance in CDSCO

The Central Drugs Standard Control Organisation (CDSCO) under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, is the National Regulatory Authority (NRA) of India.

Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002, and also has six zonal offices, four sub-zonal offices, thirteen Port offices, and seven laboratories spread across the country.

Post: Director (Vigilance)

Applications are invited from eligible candidates for appointment on deputation (including short-term contract) basis to the post of Director (Vigilance), Group ‘A’, Level 13 (Rs. 1,23,100–2,15,900) (revised) in the Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare, New Delhi.

Pay : Level 13 (Rs. 1,23,100-2,15,900)

Method of recruitment Eligibility Criteria : Deputation (including short-term contract) Officers of the Central Government or the State Governments or Union territories or Universities or recognized Research Institutions or Public Sector Undertakings or semi-Government or Statutory or Autonomous Organisations who have completed fourteen years of Group ‘A’ service and have been granted non- functional Selection Grade (NFSG) in their respective cadre.

Note 1: Selection and appointment for the post of Director (Vigilance) are to be made in accordance with the guidelines circulated by the DOP&T vide their O.M. No. 372/8/99-AVD.

II dated 18.01.2001 on the subject “Procedure for selection and appointment of Chief Vigilance Officers in the various Central Public Sector Undertakings: and as amended from time to time

Note 2: Period of deputation (including Short Term Contract) including the period of deputation (including Short Term Contract) in another ex-cadre post held immediately preceding this appointment in the same or some other organization or department of the Central Government shall not exceed five years.

Note 3: The maximum age limit for appointment by deputation shall not be exceeding 56 years as of the closing date of receipt of applications.

To exercise check and supervision on vigilance and anti-corruption work in the Central Drugs Standard Control Organization as per rules laid down in the Vigilance Manual and instructions of the Central Vigilance Commission.

The list of enclosures to be sent with the application

1. Application in prescribed format – Annexure-II duly filled, signed by the candidate and countersigned with seal by the Cadre/Appointing authority.

2. Attested copies of APARs/ACRs for the last 5 (five) years duly attested on each page with seal by an officer, not below the rank of Under Secretary to the Government of India

3. Integrity Certificate

4. Vigilance Clearance Certificate

5. Statement of major or minor penalties, if any, imposed on the officer during the last 10 years of service.

6. A certificate to the effect that the particulars furnished by the candidate have been verified and found correct as per service records.

7. Cadre Clearance Certificate

Note: Incomplete applications or applications not accompanied by the above documents will be summarily rejected.

The Cadre authorities/Head of Departments are requested to forward applications of eligible and willing candidates whose services can be spared on a deputation (including short-term contract) basis so as to reach the undersigned within 60 days from the date of publication of this advertisement in the Employment News.

The Application Form/Curriculum Vitae proforma is in Annexure II.

Directorate General of Health Services
Central Drugs Standard Control Organization (HQ),
FDA Bhawan, Kotla Road, New Delhi

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore